Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus on the treatment of dysphagia in Parkinson's disease.
Schindler A, Pizzorni N, Cereda E, Cosentino G, Avenali M, Montomoli C, Abbruzzese G, Antonini A, Barbiera F, Benazzo M, Benarroch E, Bertino G, Clavè P, Cortelli P, Eleopra R, Ferrari C, Hamdy S, Huckabee ML, Lopiano L, Marchese-Ragona R, Masiero S, Michou E, Occhini A, Pacchetti C, Pfeiffer RF, Restivo DA, Rondanelli M, Ruoppolo G, Sandrini G, Schapira A, Stocchi F, Tolosa E, Valentino F, Zamboni M, Zangaglia R, Zappia M, Tassorelli C, Alfonsi E. Schindler A, et al. Among authors: eleopra r. J Neurol Sci. 2021 Nov 15;430:120008. doi: 10.1016/j.jns.2021.120008. Epub 2021 Sep 27. J Neurol Sci. 2021. PMID: 34624796 Free article. Review.
Management of parotid sialocele with botulinum toxin.
Marchese Ragona R, Blotta P, Pastore A, Tugnoli V, Eleopra R, De Grandis D. Marchese Ragona R, et al. Among authors: eleopra r. Laryngoscope. 1999 Aug;109(8):1344-6. doi: 10.1097/00005537-199908000-00032. Laryngoscope. 1999. PMID: 10443847 No abstract available.
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, Manfredi M, Epifanio A, Sensi M, Scaravilli T, Bracco F, Eleopra R, Morgante L, Donati E, Marconi R, Abbruzzese G, Bonuccelli U, Zappia M, Colao A, Barone P. Pellecchia MT, et al. Among authors: eleopra r. Ann Neurol. 2006 Nov;60(5):611-615. doi: 10.1002/ana.20956. Ann Neurol. 2006. PMID: 16958123
The Italian Dystonia Registry: rationale, design and preliminary findings.
Defazio G, Esposito M, Abbruzzese G, Scaglione CL, Fabbrini G, Ferrazzano G, Peluso S, Pellicciari R, Gigante AF, Cossu G, Arca R, Avanzino L, Bono F, Mazza MR, Bertolasi L, Bacchin R, Eleopra R, Lettieri C, Morgante F, Altavista MC, Polidori L, Liguori R, Misceo S, Squintani G, Tinazzi M, Ceravolo R, Unti E, Magistrelli L, Coletti Moja M, Modugno N, Petracca M, Tambasco N, Cotelli MS, Aguggia M, Pisani A, Romano M, Zibetti M, Bentivoglio AR, Albanese A, Girlanda P, Berardelli A. Defazio G, et al. Among authors: eleopra r. Neurol Sci. 2017 May;38(5):819-825. doi: 10.1007/s10072-017-2839-3. Epub 2017 Feb 18. Neurol Sci. 2017. PMID: 28215037
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up.
Sensi M, Cossu G, Mancini F, Pilleri M, Zibetti M, Modugno N, Quatrale R, Tamma F, Antonini A; ITALIAN LEVODOPA CARBIDOPA INTESTINAL GEL WORKING GROUP. Sensi M, et al. Parkinsonism Relat Disord. 2017 May;38:90-92. doi: 10.1016/j.parkreldis.2017.02.020. Epub 2017 Feb 21. Parkinsonism Relat Disord. 2017. PMID: 28238650
Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.
Lopiano L, Modugno N, Marano P, Sensi M, Meco G, Solla P, Gusmaroli G, Tamma F, Mancini F, Quatrale R, Zangaglia R, Bentivoglio A, Eleopra R, Gualberti G, Melzi G, Antonini A. Lopiano L, et al. Among authors: eleopra r. J Neurol. 2019 Sep;266(9):2164-2176. doi: 10.1007/s00415-019-09337-6. Epub 2019 May 27. J Neurol. 2019. PMID: 31134377 Free PMC article.
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study.
Moccia M, Frau J, Carotenuto A, Butera C, Coghe G, Barbero P, Frontoni M, Groppo E, Giovannelli M, Del Carro U, Inglese C, Frasson E, Castagna A, Buccafusca M, Latino P, Nascimbene C, Romano M, Liotti V, Lanfranchi S, Rapisarda L, Lori S, Esposito M, Maggi L, Petracca M, Lo Fermo S, Altavista MC, Bono F, Eleopra R, Brescia Morra V. Moccia M, et al. Among authors: eleopra r. Neurol Sci. 2020 Oct;41(10):2781-2792. doi: 10.1007/s10072-020-04392-8. Epub 2020 Apr 12. Neurol Sci. 2020. PMID: 32281038
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson's Disease?
Fabbri M, Zibetti M, Rizzone MG, Giannini G, Borellini L, Stefani A, Bove F, Bruno A, Calandra-Buonaura G, Modugno N, Piano C, Peppe A, Ardolino G, Romagnolo A, Artusi CA, Berchialla P, Montanaro E, Cortelli P, Luigi R, Eleopra R, Minafra B, Pacchetti C, Tufo T, Cogiamanian F, Lopiano L. Fabbri M, et al. Among authors: eleopra r. Mov Disord. 2020 Aug;35(8):1379-1387. doi: 10.1002/mds.28091. Epub 2020 May 25. Mov Disord. 2020. PMID: 32449542 Clinical Trial.
199 results